The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study

Publication | Open Access

DOI Full Paper Access

Citations

References

2022

Year

Emre Yekedüz, Deniz Tural, İsmail Ertürk, Serdar Karakaya, Cihan Erol, Özlem Erçelep, Çağatay Arslan, Özlem Nuray Sever, Saadettin Kılıçkap, Nihan Şentürk Öztaş,

Journal of Cancer Research and Clinical Oncology

Pan-immune-inflammation ValueUrologySurvival OutcomesCancer ImmunosurveillanceGenitourinary CancerMedicineImmunologyImmune Checkpoint InhibitorOncologyTumor MicroenvironmentSecond Line